NM_001807.6(CEL):c.2007dup (p.Val670fs) AND Maturity-onset diabetes of the young type 8

delete

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Nov 18, 2018
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001333970.1

Allele description

NM_001807.6(CEL):c.2007dup (p.Val670fs)

Gene:

CEL:carboxyl ester lipase [Gene - OMIM - HGNC]

Variant type:

Duplication

Cytogenetic location:

9q34.13

Genomic location:

Preferred name:

NM_001807.6(CEL):c.2007dup (p.Val670fs)

HGVS:

NC_000009.12:g.133071509dup
NG_016394.1:g.14532dup
NM_001807.6:c.2007dupMANE SELECT
NP_001798.3:p.Val670fs
NC_000009.11:g.135946896dup
NM_001807.3:c.2016dupC

Protein change:

V670fs

Molecular consequence:

NM_001807.6:c.2007dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:: Maturity-onset diabetes of the young type 8 (MODY8)
Synonyms:: Diabetes and pancreatic exocrine dysfunction; Diabetes-pancreatic exocrine dysfunction syndrome; Diabetes mellitus MODY type 8
Identifiers:: MONDO: MONDO:0012348; MedGen: C1853297; Orphanet: 552; OMIM: 609812

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001526694	Baylor Genetics	criteria provided, single submitter (ACMG Guidelines, 2015)	Pathogenic (Nov 18, 2018)	de novo	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001526694

Baylor Genetics

criteria provided, single submitter

(ACMG Guidelines, 2015)

Pathogenic
(Nov 18, 2018)

de novo

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	de novo	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Baylor Genetics, SCV001526694.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	de novo	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Apr 13, 2021

ClinVar

Relating variation to medicine